TheraGauze study
This article was originally published in The Gray Sheet
Executive Summary
Investigators at the Combat Casualty Care Research Program at Fort Detrick in Frederick, Md., will direct a multi-site clinical study on the feasibility of using Soluble Systems' TheraGauze as a battlefield wound dressing and antimicrobial release platform, with $800,000 in federal funding contained in the fiscal 2010 defense appropriations bill, enacted last year. Soluble Systems said Feb. 10 that advanced research is needed to confirm the product's capabilities in fighting acute infections, including methicillin-resistant staphylococcus aureus (MRSA)